007HO15927 BOLT ACTION

Print/PDF
Registration Name RMD-DOTTERER BOLT ACTION-ET
Registration Number HO840003214742229
Primary NAAB Code 007HO15927
Secondary Code(s) 507HO15927, 585HO15927
Status Inactive
Controller Name Select Sires (7)
Date of Birth 2/25/2021
aAa 234
DMS 135,561
GFI 12.5%
Genetic Codes * TD TC TL TR TP TV TY TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T
Sire RMD-DOTTERER SSI GAMEDAY-ET
MGS S-S-I PR RENEGADE-ET
Beta Casein A2A2
Kappa Casein AA
Beta Lactoglobulin AA
INDEXES
NM$ 800, 89% R CM$ 837
NM Percentile 91% FM$ 719
GTPI 3322 GM$ 795
PRODUCTION TRAITS
2318 Dtrs 60 herds 100 % US 99% R
Milk 782 Fat, % 105 , +0.27%
SCS 2.71, 98% R Protein, % 45 , +0.07%
Feed Saved 35 , 55% R Milking Speed 7.28 , 85% R
Health & Fertility
Productive Life 2.6      90% R Mastitis 1.2      84% R
Heifer Livability 0.7       68% R Metritis -0.9      92% R
Livability -2.9      86% R D. Abom 0.3      95% R
DPR -0.4      95% R Ketosis 0.5      86% R
FSC -        - R. Placenta 0.3      93% R
HCR -0.3      97% R Milk Fever 0.1      80% R
CCR 0.6      94% R
SCR 0.6      95% R
DIA -        -
RSP -        -
Calving Traits
Sire CE 1.1      97% R 1652 Obs
Daughter CE 1.9      85% R 148 Obs, 148 Dtrs
Sire SB 4.1      93% R 1370 Obs
Daughter SB 3.6      80% R 125 Obs, Dtrs
Gestation Length -0.8      99% R 24 Obs, 1364 Dtrs
Early First Calving 3.3      77% R 0 Obs, 0 Dtrs

CDCB April 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 04/2026
69 Dtrs 21 herds 92% R
PTA Type 1.18 UDC 1.68
HCC BWC -0.48
FLC 0.28
Linear Traits
Stature 0.06
Tall
Strength -0.31
Strong
Body Depth -0.40
Shallow
Dairy Form 0.55
Open
Rump Angle 0.25
Sloped
Thurl Width 0.13
Sloped
Rear Legs-Side View 0.13
Wide
Rear Legs-Rear View -0.01
H.-in
Foot Angle 0.79
Steep
Feet & Legs Score 0.33
High
F.U. Attachment 0.66
Curved
Rear Udder Height 1.99
High
Rear Udder Width 2.05
Wide
Udder Cleft 0.48
Strong
Udder Depth -0.01
H.-in
Front Teat Placement 1.56
Close
Rear Teat Placement 1.39
Close
Teat Length -1.44
Short
-2
0
2

CDCB April 2026; Base of Evaluation: HO